Changeflow GovPing Healthcare & Life Sciences Theravectys Trademark Renewal
Routine Notice Amended Final

Theravectys Trademark Renewal

Favicon for changeflow.com USPTO Trademarks - Medical Services (Class 044)
Published
Detected
Email

Summary

The USPTO has renewed the trademark application TM79427841 for Theravectys, which covers a range of medical research, pharmaceutical preparations, and manufacturing services. The renewal is effective March 24, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has processed a renewal for trademark application TM79427841, filed under the name Theravectys. This renewal pertains to services including scientific research for medical purposes, pharmaceutical development, clinical trials, and the manufacturing of pharmaceutical preparations and vaccines, particularly for cancer and infectious diseases. The renewal is effective March 24, 2026.

This action signifies the continued protection of Theravectys's intellectual property related to its medical and pharmaceutical offerings. While this is a routine renewal, it confirms the company's ongoing commitment to its research, development, and manufacturing activities in these critical health sectors. No new compliance obligations are imposed by this renewal; it primarily serves to maintain existing trademark rights.

Archived snapshot

Mar 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

THERAVECTYS

Renewed TM79427841 Kind: renewed Mar 24, 2026

Abstract

Scientific research for medical purposes; research and development services for pharmaceutical preparations; conducting clinical trials in the nature of scientific research; clinical research for scientific purposes; conducting scientific feasibility studies and analyses; biological, biotechnological, biochemical, medical and pharmaceutical research and development services for third parties; evaluation of the efficacy of pharmaceutical products.; Pharmaceutical and veterinary preparations for the treatment of cancer, infectious diseases and emerging infectious diseases; vaccines; pharmaceutical preparations containing lentiviral vectors for medical, pharmaceutical and veterinary use, particularly for the treatment of cancer, infectious diseases and emerging infectious diseases; chemical, biological and pharmaceutical preparations for therapeutic, medical, pharmaceutical and veterinary use, particularly for the treatment of cancer, infectious diseases and emerging infectious diseases; diagnostic preparations for therapeutic, medical and veterinary use; chemical reagents for medical or veterinary use.; Chemical preparations for use in industry and science; chemical preparations for scientific use, other than for medical or veterinary use; biological preparations for use in industry and science; chemical reagents other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary use; lentiviral vectors for scientific research.; Medical analysis and medical diagnosis services for the treatment of cancer, infectious diseases and emerging infectious diseases; medical analyses of blood samples; medical assistance services relating to medicine and health care; provision of medical information.; Pharmaceutical product custom manufacturing to order for third parties; vaccine manufacturing services to order for third parties.

Filing Date

2025-05-15

View original document →

Get daily alerts for USPTO Trademarks - Medical Services (Class 044)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM79427841

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 6211 Healthcare Providers
Activity scope
Pharmaceutical Manufacturing Clinical Trial Reporting Drug Labeling
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Intellectual Property Medical Services

Get alerts for this source

We'll email you when USPTO Trademarks - Medical Services (Class 044) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!